1. What Is the Remote Diabetes Monitoring Market?
The Remote Diabetes Monitoring Market encompasses technology systems, clinical services, and integrated platforms for monitoring diabetes patients between scheduled clinic visits. They enable healthcare providers and care management teams to monitor glucose data, device data, and clinical parameters through digital data transmission. The market includes CGM remote monitoring platforms, telehealth diabetes clinical services, remote patient monitoring programmes for high-risk diabetes populations, digital care management services for payer diabetes programmes, and employer-based diabetes remote monitoring benefits. These services are deployed by endocrinologists, primary care teams, diabetes educators, and care management organisations to identify glycaemic deterioration, medication non-adherence, and device problems in between-visit monitoring windows and intervene before deterioration requires emergency care. Market scope covers clinical and payer-contracted remote diabetes monitoring services and their associated technology infrastructure. It excludes consumer wellness CGM programmes without clinical programme integration, diabetes management software without active clinical monitoring, and standalone telemedicine visits without continuous monitoring between sessions.
2. Remote Diabetes Monitoring Market Size & Forecast
3. Emerging Technologies
- AI-automated glycaemic alert triage technology is advancing machine learning models integrated into CGM remote monitoring platforms that classify incoming CGM alert urgency, route non-urgent alerts to patient self-management education and urgent alerts to immediate. Growing industry adoption of this technology is motivating development.
- Predictive hospitalisation risk scoring from remote monitoring data is advancing machine learning models that identify diabetes patients at high short-term risk of emergency department visit or hospitalisation from CGM variability patterns, medication refill gaps. Growing industry adoption of this technology is motivating development.
- Remote CGM monitoring programme reimbursement code expansion is advancing regulatory and payer policy development to extend Medicare RPM billing eligibility to additional diabetes CGM device types and broaden commercial payer reimbursement for between-visit. Growing.
- International telemedicine diabetes specialist access is advancing cross-border virtual endocrinology consultation platforms that enable patients in countries with limited endocrinology specialist density to access remote CGM-guided diabetes management services from specialist providers. Growing industry adoption of this technology is motivating development.
Similar technologies are also transforming adjacent markets. Learn more in our Diabetes Care Platform Market.
4. Key Market Opportunity
One of the major opportunities in the Remote Diabetes Monitoring Market is the expansion of Medicare remote patient monitoring programme adoption at primary care practices to provide CGM-guided diabetes management for high-risk elderly type 2 diabetes patients between quarterly clinic visits. A significant proportion of high-risk elderly Medicare diabetes patients with suboptimal glycaemic control are managed in primary care quarterly clinic visits where between-visit deterioration is not detected until the next HbA1c measurement, generating preventable hypoglycaemia episodes and hospitalisation. Medicare RPM reimbursement codes enable primary care practices to bill for CGM device setup and daily monitoring services that detect between-visit glycaemic deterioration and trigger proactive patient contact before deterioration requires emergency care or hospitalisation. Remote diabetes monitoring platform vendors that develop primary care-compatible RPM workflow tools with automated CGM alert management, compliant billing documentation, and practice integration capability are positioned to capture the large primary care Medicare diabetes RPM market.
5. Top Companies in the Remote Diabetes Monitoring Market
The following organisations hold leading positions in the Remote Diabetes Monitoring Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Teladoc Health (Livongo)
- Biofourmis
- Virta Health
- Onduo (Verily)
- Dexcom (Clarity)
- Abbott (LibreView)
- Omada Health
- Glooko
- Tidepool
- Nuvation Health
6. Market Segmentation
The Remote Diabetes Monitoring Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Service Type | CGM Remote Monitoring Service Clinical CGM Review Service Automated Alert Remote Monitoring Telehealth Diabetes Service Virtual Endocrinology Visit Remote Diabetes Education RPM Programme Management RPM Device and Platform High-Risk Diabetes RPM Care Management Service Diabetes Nurse Case Management Population Health DM Programme Employer Remote DM Programme Employer CGM Monitoring Benefit |
| By Payer | Commercial Health Insurance Commercial CGM Remote Medicare and Medicaid Medicare Diabetes RPM Employer Self-Insured Employer DM Remote Monitoring Value-Based Care ACO Diabetes Remote Monitoring |
| By Technology Platform | CGM Data Platform CGM Dashboard Remote EHR-Integrated RPM EHR Remote Monitoring Module Standalone RPM Platform Third-Party RPM Service Telephone and Video Telemedicine Diabetes Visit |
| By End User | Endocrinology Practices Specialist Remote Monitoring Primary Care Practices GP Diabetes Remote Monitoring Hospital Systems Health System DM RPM Payer Organisations Health Plan Diabetes Monitoring |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Remote Diabetes Monitoring Market trajectory over the forecast period:
CGM-Based Remote Monitoring Technology Is Enabling Endocrinologists to Detect and Address Glycaemic Deterioration Between Clinic Visits for High-Risk Diabetes Patients.Endocrinologists managing high-risk type 1 and type 2 diabetes patients with recurring hypoglycaemia, frequent emergency department visits, and suboptimal HbA1c are implementing CGM remote monitoring programmes where diabetes educators review CGM data dashboards daily. Contact patients with dose adjustment guidance without requiring a clinic visit. Dexcom Clarity remote monitoring and Abbott LibreView care portal continued commercial expansion for clinical team CGM remote monitoring in 2024. This grows endocrinology practice adoption of daily CGM dashboard review as a standard between-visit service for high-risk diabetes patients.
Medicare Remote Patient Monitoring Reimbursement Technology Is Enabling Diabetes Practices to Bill for CGM Monitoring Services Between Clinic Visits.Endocrinology and primary care practices establishing diabetes remote monitoring programmes are using Medicare CPT 99453, 99454. Additionally and 99457 remote patient monitoring billing codes to generate fee-for-service revenue for CGM device setup, daily monitoring, monthly care management services provided between scheduled diabetes clinic visits. Teladoc Health, Biofourmis, and specialised diabetes RPM vendors continued development of billing-compliant remote patient monitoring diabetes programme infrastructure in 2024. This enables endocrinology and primary care practices to establish reimbursable CGM monitoring services with automated CPT code documentation.
Employer-Sponsored Remote Diabetes Monitoring Technology Is Providing Population-Level CGM Monitoring Benefits for High-Risk Diabetic Employees.Large self-insured United States employers are contracting remote diabetes monitoring benefits that provide high-risk diabetic employees with CGM devices, remote monitoring by a diabetes care team, proactive intervention for deteriorating glycaemic control. As a medical cost reduction benefit. Virta Health, Onduo, and employer-focused digital diabetes management companies continued commercial expansion of employer remote diabetes monitoring programme contracts in 2024. This demonstrates medical cost reduction through glycaemic control improvement and hospitalisation reduction for employer-enrolled high-risk diabetes populations.
For related market intelligence, see the Diabetes Management Software Market.
8. Segmental Analysis
By service type, CGM remote monitoring services dominated the Remote Diabetes Monitoring Market in 2025, driven by the growing CGM user base requiring clinical integration and Medicare remote patient monitoring reimbursement for CGM-based between-visit monitoring. Endocrinologists and primary care practices with established CGM monitoring programmes continue generating the highest remote diabetes monitoring demand as CGM remote review becomes the standard between-visit service for high-risk insulin-using diabetes patients. Telehealth diabetes services are the fastest-growing service type, driven by growing patient and physician preference for virtual endocrinology and diabetes education visits that eliminate travel burden and enable more frequent clinical contact. Endocrinologists and diabetes educators are increasing telehealth visit volume as patients prefer virtual appointment convenience and evidence demonstrates equivalent glycaemic improvement from telehealth versus in-person diabetes visit protocols.
By payer, commercial health insurance dominated the Remote Diabetes Monitoring Market in 2025, driven by large employer self-insured remote diabetes monitoring programme contracting and commercial payer coverage for CGM remote monitoring services. Employers and commercial payers continue generating the highest remote diabetes monitoring revenue as self-insured employer digital diabetes programme contracts provide per-member monitoring fees for large enrolled diabetic populations. Medicare and Medicaid is the fastest-growing payer segment, driven by expanding Medicare RPM reimbursement framework adoption and growing CMS programme incentives for remote diabetes management in the large Medicare diabetes beneficiary population. Endocrinology and primary care practices are increasing Medicare remote diabetes monitoring programme implementation as RPM billing codes provide fee-for-service revenue for CGM monitoring and Medicare Advantage plans contract remote management as a quality investment.
9. Regional Analysis
Regional demand patterns across the Remote Diabetes Monitoring Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Remote Diabetes Monitoring Market in 2025, with a market share of 46.0%. The region's leadership reflects the established Medicare remote patient monitoring reimbursement framework creating billing incentives for United States diabetes practices to implement CGM monitoring services, the large employer-sponsored digital diabetes management market, and the concentration of remote diabetes monitoring platform vendors with North American commercial operations. The United States Medicare RPM reimbursement framework for CPT 99453, 99454, and 99457 billing generates financial incentives for endocrinology and primary care practices to establish CGM remote monitoring programmes for Medicare diabetes patients, creating systematic commercial adoption. Growing United States employer self-insured market remote diabetes monitoring programme contracting is generating consistent demand for integrated monitoring platforms that provide medical cost reduction evidence through HbA1c improvement and hospitalisation reduction for employer-enrolled diabetic populations.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 14.30% during the forecast period. Growing type 2 diabetes prevalence, expanding telemedicine infrastructure, and increasing government and private payer investment in digital diabetes disease management programmes in China, Japan, South Korea, India, and Southeast Asia are creating demand for remote diabetes monitoring services. Growing Japanese and South Korean government digital health investment and national health insurance telemedicine reimbursement framework development are creating conditions for remote endocrinology and CGM monitoring service adoption at diabetes specialist practices. Growing diabetes specialist shortage in India and Southeast Asia, combined with expanding smartphone and broadband access enabling telemedicine engagement, is creating demand for remote diabetes monitoring platforms providing specialist-quality diabetes oversight to underserved patient populations.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Remote Diabetes Monitoring Market was valued at USD 4.51 Bn in 2025 and is projected to reach USD 11.54 Bn by 2034, growing at a CAGR of 11.00% over the 2026–2034 forecast period.
The Remote Diabetes Monitoring Market is projected to grow at a CAGR of 11.00% from 2026 to 2034.
North America dominated the Remote Diabetes Monitoring Market in 2025, with a market share of 46.0%.
The leading companies in the Remote Diabetes Monitoring Market include Teladoc Health (Livongo), Biofourmis, Virta Health, Onduo (Verily), Dexcom (Clarity), Abbott (LibreView), Omada Health, Glooko, Tidepool, Nuvation Health.
Cgm-based remote monitoring technology is enabling endocrinologists to detect and address glycaemic deterioration between clinic visits for high-risk diabetes patients.
By service type, CGM remote monitoring services dominated the Remote Diabetes Monitoring Market in 2025, driven by the growing CGM user base requiring clinical integration and Medicare remote patient monitoring reimbursement for CGM-based between-visit monitoring.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.